Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

2
results for

"Koreans"

Keywords

Publication year

"Koreans"

Original Articles

Viral hepatitis

A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C
Byung Chul You, Young Seok Kim, Hun il Kim, Se Hun Kim, Seung Sik Park, Yu Ri Seo, Sang Gyune Kim, Se Whan Lee, Hong Soo Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim
Korean J Hepatol 2012;18(3):272-278.
Published online September 25, 2012
DOI: https://doi.org/10.3350/cmh.2012.18.3.272
Background/Aims

When combined with pegylated interferon alpha-2b (Peg-IFN α-2b) for the treatment of genotype 1 chronic hepatitis C (CHC) in Korea, the current guideline for the initial ribavirin (RBV) dose is based on body weight. However, since the mean body weight is lower for Korean patients than for patients in Western countries, current guidelines might result in Korean patients being overdosed with RBV.

Methods

We retrospectively reviewed the medical records of patients with genotype 1 CHC who were treated with Peg-IFN α-2b and RBV combination therapy. We divided the patients into groups A (≥15 mg/kg/day, n=23) and B (<15 mg/kg/day, n=26), given that the standard dose is 15 mg/kg/day. The clinical course in terms of the virologic response, adverse events, and dose modification rate was compared between the two groups after therapy completion.

Results

The early response rates (92.0% vs. 83.3%, P=0.634) and sustained virologic response rates (82.6% vs. 73.1%, P=0.506) did not differ significantly between the two groups. During the treatment period, the RBV dose reduction rate was significantly higher in group A than in group B (60.9% vs. 23.1%, P=0.01).

Conclusions

RBV dose reduction is performed frequently when patients are treated according to the current Korean guidelines. Given that lowering the RBV dose did not appear to decrease the virologic response during therapy, reducing RBV doses below the current Korean guideline may be effective for treatment, especially in low-weight patients.

Citations

Citations to this article as recorded by  Crossref logo
  • The Impact of Inosine Triphosphatase Variants on Hemoglobin Level and Sustained Virologic Response of Chronic Hepatitis C in Korean
    Ju Seung Kim, Sung-Min Ahn, Young Kul Jung, Oh Sang Kwon, Yun Soo Kim, Duck Joo Choi, Ju Hyun Kim
    Journal of Korean Medical Science.2013; 28(8): 1213.     CrossRef
  • 10,040 View
  • 44 Download
  • Crossref
The Relationship Between Serum Adiponectin Level and Serum Alanine Aminotransferase Elevation in Korean Male with Nonalcoholic Fatty Liver Disease
Yong Su Lee, M.D., Yong Kyun Cho, M.D., Ji Cheul Pae, M.D., Se Yong Oh, M.D., Mun Su Kang, M.D., Jung Ho Park, M.D., Hong Joo Kim, M.D., Dong Il Park, M.D., Chong Il Sohn, M.D., Woo Kyu Jeon, M.D., Byung Ik Kim, M.D., Won Young Lee, M.D., Ki Won Oh, M.D.1, Eun Joo Yun, M.D.2, and Eun Sook Oh, M.D.3
Korean J Hepatol 2006;12(2):221-229.
Background/Aims
Nonalcoholic fatty liver disease (NAFLD) comprises a large part of chronic liver diseases. Recently it was reported that adipokines are closely associated with the common risk factors for NAFLD, such as obesity, diabetes, dyslipidemia, and insulin resistance. We aimed to evaluate the changes in serum adiponectin, resistin and leptin concentrations related to alanine aminotransferase (ALT) elevations in Korean men with NAFLD. Methods: We studies 38 men who were diagnosed with fatty liver by abdominal ultrasonography. None had a history of excessive alcohol consumption, autoimmune hepatitis, inherited or metabolic liver disease or viral hepatitis. The subjects were divided into two groups. One group had normal levels of ALT (n=28) and the other had increased ALT (n=10). We compared anthropometrical parameters, biochemical items and serum adipokine levels between these two groups. Results: Serum adiponectin levels were lower in the increased ALT group than in the normal ALT group (3.89±1.77 vs 7.01±2.54 ?g/dL, P=0.001). But there were no significant differences in serum leptin and resistin levels between two groups (4.02±2.04 vs 3.26±1.41 ng/mL, p=0.245, 80.14±14.8 vs 80.5±11.34 ng/mL, P=0.937, respectively). Multiple linear regression analyses demonstrated that the serum adiponectin level is inversely correlated with serum ALT level and that the serum aspartate aminotransferase (AST) level is positively correlated with the serum ALT level. Conclusions: Our study shows that hypoadiponectinemia is associated with an ALT elevation in patients with NAFLD. Adiponectin may play an indirect role in the development of NAFLD. (Korean J Hepatol 2006;12:221-229)
  • 3,613 View
  • 24 Download